| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.16 | 9e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.15 | 0.0006 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.2 | 0.0008 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0009 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |